IL130716A - (-) E - 2 (-4,3 dichlorocinamyl) - 1 cyclopropylmethyl-piperidine and its use in the preparation of anti-diarrheal preparations - Google Patents
(-) E - 2 (-4,3 dichlorocinamyl) - 1 cyclopropylmethyl-piperidine and its use in the preparation of anti-diarrheal preparationsInfo
- Publication number
- IL130716A IL130716A IL13071698A IL13071698A IL130716A IL 130716 A IL130716 A IL 130716A IL 13071698 A IL13071698 A IL 13071698A IL 13071698 A IL13071698 A IL 13071698A IL 130716 A IL130716 A IL 130716A
- Authority
- IL
- Israel
- Prior art keywords
- dichlorocinnamyl
- piperidine
- preparation
- cyclopropylmethylpiperidine
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9702713A FR2760455B1 (fr) | 1997-03-05 | 1997-03-05 | (-)e-2-(3,4-dichloro-cinnamyl)-1-cyclopropylmethyl- piperidine, son utilite antidiarrheique |
| PCT/EP1998/001564 WO1998039296A1 (fr) | 1997-03-05 | 1998-03-04 | (-)e-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine et son utilisation comme antidiarrheique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL130716A0 IL130716A0 (en) | 2000-06-01 |
| IL130716A true IL130716A (en) | 2004-02-19 |
Family
ID=9504511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13071698A IL130716A (en) | 1997-03-05 | 1998-03-04 | (-) E - 2 (-4,3 dichlorocinamyl) - 1 cyclopropylmethyl-piperidine and its use in the preparation of anti-diarrheal preparations |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6440997B2 (fr) |
| EP (1) | EP0968187A1 (fr) |
| JP (1) | JP2001513802A (fr) |
| KR (1) | KR20000075973A (fr) |
| AU (1) | AU749902B2 (fr) |
| BR (1) | BR9808823A (fr) |
| CA (1) | CA2277839A1 (fr) |
| FR (1) | FR2760455B1 (fr) |
| IL (1) | IL130716A (fr) |
| NZ (1) | NZ336575A (fr) |
| WO (1) | WO1998039296A1 (fr) |
| ZA (1) | ZA981849B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1138327A1 (fr) * | 2000-03-29 | 2001-10-04 | Warner-Lambert Company | Utilisation de dérivés 2-(arylalkenyl)azacycloalkanes pour traiter les désordres gastrointestinaux liés au stress |
| FR2833945B1 (fr) * | 2001-12-21 | 2004-03-12 | Warner Lambert Co | N-cyclopropylmethyl-azacycloalcanes, compositions les contenant et procedes de preparation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849760A (en) * | 1993-12-09 | 1998-12-15 | Institut De Recherche Jouveinal | 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors |
-
1997
- 1997-03-05 FR FR9702713A patent/FR2760455B1/fr not_active Expired - Fee Related
-
1998
- 1998-03-04 JP JP53819398A patent/JP2001513802A/ja not_active Abandoned
- 1998-03-04 WO PCT/EP1998/001564 patent/WO1998039296A1/fr not_active Application Discontinuation
- 1998-03-04 AU AU70367/98A patent/AU749902B2/en not_active Ceased
- 1998-03-04 ZA ZA981849A patent/ZA981849B/xx unknown
- 1998-03-04 US US09/367,579 patent/US6440997B2/en not_active Expired - Fee Related
- 1998-03-04 NZ NZ336575A patent/NZ336575A/en unknown
- 1998-03-04 BR BR9808823-8A patent/BR9808823A/pt not_active IP Right Cessation
- 1998-03-04 IL IL13071698A patent/IL130716A/en not_active IP Right Cessation
- 1998-03-04 CA CA002277839A patent/CA2277839A1/fr not_active Abandoned
- 1998-03-04 EP EP98916993A patent/EP0968187A1/fr not_active Ceased
- 1998-03-04 KR KR1019997008058A patent/KR20000075973A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2277839A1 (fr) | 1998-09-11 |
| FR2760455B1 (fr) | 1999-04-16 |
| AU7036798A (en) | 1998-09-22 |
| EP0968187A1 (fr) | 2000-01-05 |
| BR9808823A (pt) | 2000-07-04 |
| US6440997B2 (en) | 2002-08-27 |
| AU749902B2 (en) | 2002-07-04 |
| NZ336575A (en) | 2001-10-26 |
| WO1998039296A1 (fr) | 1998-09-11 |
| IL130716A0 (en) | 2000-06-01 |
| JP2001513802A (ja) | 2001-09-04 |
| US20010008897A1 (en) | 2001-07-19 |
| KR20000075973A (ko) | 2000-12-26 |
| FR2760455A1 (fr) | 1998-09-11 |
| ZA981849B (en) | 1998-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3833116B2 (ja) | ビフェニル誘導体、その製法及び薬剤としての使用 | |
| NO171453B (no) | Fremgangsmaate for fremstilling av krystallinsk paroxetin-hydroklorid-hemihydrat | |
| KR20000064411A (ko) | 새로운방법 | |
| EP0645391B1 (fr) | Dérivés benzamides | |
| WO2004082623A2 (fr) | Composes piperidine substituee | |
| UA73530C2 (uk) | Сполука з властивостями вивільнювати гормон росту | |
| AU697003B2 (en) | Novel n-substituted naphthofused lactams | |
| US5250537A (en) | 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indole,-6,7,8,9,10-hexahydro-7,11-imino-5H-cyclooct[b]indole and substituted derivatives | |
| US6440997B2 (en) | −E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethylpiperidine, and its antidiarrhoeal use | |
| IE59653B1 (en) | Pyrrolo[1,2-a][4,1]benzoxyzepine derivatives, process for their preparation, compounds and their therapeutic use | |
| WO1998039295A1 (fr) | (r)n-(1-cyclopropylmethylpyrrolidine-2-ylmethyl)benzamide et son utilisation comme antidiarrheique | |
| US6787563B2 (en) | Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate | |
| MXPA99006192A (en) | (-)e-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine and its antidiarrhoeal use | |
| FI61687C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara ala-metyl-3,4-dihydroxifenylalaninderivat | |
| SI9210325A (en) | Condensed diazepinones, process for their preparation and compositions containing them for the treatment of the central nervous system and to enhance cerebral perfusion | |
| US5635518A (en) | N-substituted azaheterocyclic carboxylic acids and esters thereof | |
| US5610155A (en) | Condensed diazepinones, processes for preparing them and agents containing these compounds for treating diseases of the central nervous system and for promoting cerebral blood circulation | |
| WO2019147182A1 (fr) | Agents anti-athérosclérotiques | |
| US5639766A (en) | N-substituted azaheterocyclic carboxylic acids and esters thereof | |
| JPH08208643A (ja) | ６−メトキシ−１ｈ−ベンゾトリアゾール−５−カルボキサミド誘導体及びそれを含有する医薬組成物 | |
| JPS58152851A (ja) | 腎蔵活性テトラペプチド | |
| WO2001025201A1 (fr) | Procede de preparation de produit intermediaire de paroxetine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees | ||
| MM9K | Patent not in force due to non-payment of renewal fees |